CureVac NV (5CV) — Financial Flexibility Index
CureVac NV (5CV) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of €30.18 Million (operating CF €29.86 Million minus capex €322.00K) represents 0% of total liabilities (€267.39 Million). Check CureVac NV PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CureVac NV Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for CureVac NV across 7 annual periods. See CureVac NV working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for CureVac NV (2018–2024)
Year-by-year free cash flow to debt coverage for CureVac NV. For the full company profile including market capitalisation, see CureVac NV (5CV) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.13x | €120.30 Million | €101.85 Million | €106.22 Million | ▲ +244.5% |
| 2023 | -0.78x | €-212.69 Million | €-267.89 Million | €271.31 Million | ▼ -32.9% |
| 2022 | -0.59x | €-192.96 Million | €-286.18 Million | €327.22 Million | ▲ +54.5% |
| 2021 | -1.30x | €-608.91 Million | €-733.13 Million | €469.77 Million | ▼ -285.6% |
| 2020 | 0.70x | €558.73 Million | €522.40 Million | €800.01 Million | ▲ +259.8% |
| 2019 | -0.44x | €-75.79 Million | €-86.96 Million | €173.42 Million | ▲ +36.8% |
| 2018 | -0.69x | €-64.70 Million | €-74.11 Million | €93.58 Million | — |